MIRA INFORM REPORT

 

 

Report Date :

30.05.2013

 

IDENTIFICATION DETAILS

 

Name :

NAM HA PHARMACEUTICAL JOINT STOCK COMPANY

 

 

Registered Office :

415 Han Thuyen Road, Vi Xuy­en Ward, Nam Dinh City, Nam Dinh Province

 

 

Country :

Vietnam

 

 

Financials (as on) :

31.12.2012

 

 

Year of Incorporation :

1960

 

 

Com. Reg. No.:

0600206147

 

 

Legal Form :

Joint stock company

 

 

Line of Business :

Manufacturing chemical drugs and pharmaceutical materials

 

 

No. of Employees :

800

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

No Complaints

Litigation :

Clear

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

Vietnam

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

VIETNAM - ECONOMIC OVERVIEW

 

Vietnam is a densely-populated developing country that has been transitioning from the rigidities of a centrally-planned economy since 1986. Vietnamese authorities have reaffirmed their commitment to economic modernization in recent years. Vietnam joined the World Trade Organization in January 2007, which has promoted more competitive, export-driven industries. Vietnam became an official negotiating partner in the Trans-Pacific Partnership trade agreement in 2010. Agriculture's share of economic output has continued to shrink from about 25% in 2000 to less than 22% in 2012, while industry's share increased from 36% to nearly 41% in the same period. State-owned enterprises account for roughly 40% of GDP. Poverty has declined significantly, and Vietnam is working to create jobs to meet the challenge of a labor force that is growing by more than one million people every year. The global recession hurt Vietnam's export-oriented economy, with GDP in 2012 growing at 5%, the slowest rate of growth since 1999. In 2012, however, exports increased by more than 18%, year-on-year; several administrative actions brought the trade deficit back into balance. Between 2008 and 2011, Vietnam's managed currency, the dong, was devalued in excess of 20%, but its value remained stable in 2012. Foreign direct investment inflows fell 4.5% to $10.5 billion in 2012. Foreign donors have pledged $6.5 billion in new development assistance for 2013. Hanoi has oscillated between promoting growth and emphasizing macroeconomic stability in recent years. In February 2011, the Government shifted policy away from policies aimed at achieving a high rate of economic growth, which had stoked inflation, to those aimed at stabilizing the economy, through tighter monetary and fiscal control. Although Vietnam unveiled a broad, "three pillar" economic reform program in early 2012, proposing the restructuring of public investment, state-owned enterprises, and the banking sector, little perceptible progress had been made by early 2013. Vietnam's economy continues to face challenges from an undercapitalized banking sector. Non-performing loans weigh heavily on banks and businesses. In September 2012, the official bad debt ratio climbed to 8.8%, though some independent analysts believe it could be higher than 15%.

Source : CIA


 

 

SUBJECT IDENTIFICATION & LEGAL FORM

 

Current legal status

English Name

 

NAM HA PHARMACEUTICAL JOINT STOCK COMPANY

Vietnamese Name

 

CONG TY CO PHAN DUOC PHAM NAM HA

Short name

 

NAMHA PHARMA

Type of Business

 

Joint stock company

Year Established

 

1960

Establishment Decision

 

353/QD-UB

Date of Issuance

 

31 Mar 1995

Place of Issuance

 

People’s Committee of Nam Dinh Province

Business Registration No.

 

0600206147

Date of Registration

 

30 Jul 2009

Place of Registration

 

Nam Dinh Department of Planning and Investment

Chartered capital

 

VND 52,000,000,000

Status

 

Unlisted

Tax code

 

0600206147

Total Employees

 

800

 

Historical Identification & Legal form

 

List

Changed Items

Date of changes

1

Subject has got former Board Of Director: Ms. NGUYEN THI KHANH VAN - General Director

Changed to: Mr. NGUYEN THANH DUONG - General Director

14 May 2013

2

Subject has got former Board Of Director: BUI HUU VIET_ General Director

Changed to: NGUYEN THI KHANH VAN_ General Director

18 Aug 2010

3

Subject has got former Business Registration No: 0703000004

Changed to: 0600206147

30 Jul 2009

4

Subject has got former Registered Vietnamese Name: CONG TY HOP DANH ICH HOA SINH changed to XI NGHIEP DUOC PHAM NAM HA in 1996, then changed to CONG TY DUOC PHAM NAM HA in June 1995 Changed to: CONG TY CO PHAN DUOC PHAM NAM HA

09 Nov 2000

5

Subject has got former Type of Business: State Owned Company Changed to: Joint Stock Company

31 Mar 1995

6

Subject has got former Registered English Name: Ich Hoa Sinh joint-state private Company Changed to Nam Ha pharmaceutical Enterprise (in 1966) Changed to Nam Ha pharmaceutical state company (in June 1995) Changed to Nam ha joint stock pharmaceutical company Then Changed to: Nam ha pharmaceutical joint stock company

09 Nov 2000

7

Subject has got former Abbreviated Name: NAPHACO

Changed to: NAMHA PHARMA

N/A

 

 

ADDRESSES

 

Head Office

Address

 

415 Han Thuyen Road, Vi Xuy­en Ward, Nam Dinh City, Nam Dinh Province, Vietnam

Telephone

 

(84-350) 3649 408

Fax

 

(84-350) 3644 650

Email

 

info@namhapharma.vn

Website

 

http://www.namhapharma.com

 

Branch in Ha Noi

Address

 

No. 96 Thai Ha Street, Dong Da District, Ha Noi City, Vietnam

Telephone

 

(84-4) 3856 2166/ 38560138

Fax

 

(84-4) 3856 2901

 

Branch in Ho Chi Minh

Address

 

182B Le Van Sy, Ward 10 , Phu Nhuan District, Ho Chi Minh City, Vietnam

Telephone

 

(84-8) 39 971172

Fax

 

(84-8) 39 971171

 

Branch in Da Nang

Address

 

No.172 Hoang Van Thai Hoa Khanh Ward, Lien Chieu District, Da Nang City, Vietnam

 

Branch in Nam Dinh

Address

 

214 Block 3 Yen Dinh Town, Hai Hau District, Nam Dinh Province, Vietnam

Telephone

 

(84-350) 3877 159

Fax

 

(84-350) 3877 159

 

 

DIRECTORS

 

1. NAME

 

Mr. DOAN VAN DOI

Position

 

Chairman

Resident

 

55/44 Khuong Thuong Airport Road, Dong Da District, Ha Noi City, Vietnam

Nationality

 

Vietnamese

Tel/Mobile phone

 

(84-4) 3852 3096

Qualification

 

Pharmacist

 

2. NAME

 

Mr. NGUYEN THANH DUONG

Position

 

General Director

Date of Birth

 

03 Jan 1958

ID Number/Passport

 

161720924

ID Issue Date

 

08 Oct 1999

ID Issue Place

 

Police Station in Nam Dinh Province

Resident

 

1521I Lot 17, Ha Long Ward Han Thuyen, Nam Dinh City, Nam Dinh Province, Vietnam

Nationality

 

Vietnamese

 

3. NAME

 

Mr. NGUYEN TRUNG TRUC

Position

 

Deputy General Director

Nationality

 

Vietnamese

Qualification

 

Pharmacist

 

4. NAME

 

Ms. NGUYEN THI THANH BINH

Position

 

Deputy General Director

Nationality

 

Vietnamese

 

5. NAME

 

Ms. HOANG THI TUYET

Position

 

Deputy General Director

Nationality

 

Vietnamese

 

6. NAME

 

Ms. NGUYEN THI THANH MAI

Position

 

Deputy General Director

Nationality

 

Vietnamese

 

7. NAME

 

Ms. MAI THUY HANG

Position

 

Chief Accountant

Nationality

 

Vietnamese

 

 

BUSINESS NATURE AND ACTIVITIES

 

The subject specializes in fields as follow:
- Manufacturing chemical drugs and pharmaceutical materials
- Manufacturing new medicine for human
- Manufacturing traditional medicines
- Manufacturing cosmetics
- Manufacturing chemical products
- Trading chemicals, industrial ethanol, wash substances
- Trading drugs, vaccines
- Manufacturing and trading nutritional supplement
- Trading medical machines, equipments and facilities
- Trading essential oil

 

 

IMPORT & EXPORT ACTIVITIES

 

IMPORT:

·         Types of products

 

Drugs, Machines, Equipments, essential oil

·         Market

 

France, Germany, Korea, China, America, England, India, Singapore, Thailand, etc.

·         Ratio

 

40%

·         Mode of payment

 

T/T, L/C, D/P

 

EXPORT:

·         Types of products

 

Drugs

·         Market

 

Cambodia, South Africa, India, Israel Australia, and Malaysia

·         Mode of payment

 

T/T, L/C, D/P

 

 

BANKERS

 

1. VIET NAM JOINT STOCK COMMERCIAL BANK FOR INDUSTRY AND TRADE NAM DINH BRANCH  (VIETINBANK NAM DINH BRANCH)

Address

 

No.119 Quang Trung, Nam Dinh City, Nam Dinh Province, Vietnam

Telephone

 

(84-350) 3867526

 

2. BANK FOR INVESTMENT AND DEVELOPMENT OF VIETNAM NAM DINH BRANCH

Address

 

92 Hung Vuong Str, Nam Dinh City, Nam Dinh Province, Vietnam

Telephone

 

(84-350) 364 8630

Fax

 

(84-350) 364 8633

Note: The subject has transacted through Vietinbank Nam Dinh Branch (not Vietin Bank Na Dinh Branch as given one).

 

 

SHAREHOLDERS

 

The list of the subject’s founding shareholders is empty in the latest license.
 

 

FINANCIAL DATA

 

BALANCE SHEET

Unit: One VND

Balance sheet date

31/12/2012

31/12/2011

31/12/2010

Number of weeks

52

52

52

ASSETS

A – CURRENT ASSETS

360,121,986,610

389,957,826,788

429,924,130,286

I. Cash and cash equivalents

19,967,999,240

33,233,820,365

62,929,422,635

1. Cash

19,967,999,240

33,233,820,365

62,929,422,635

2. Cash equivalents

0

 

0

II. Short-term investments

0

 

0

1. Short-term investments

0

 

0

2. Provisions for devaluation of short-term investments

0

 

0

III. Accounts receivable

143,992,511,101

101,978,265,041

107,186,065,277

1. Receivable from customers

120,219,940,014

89,699,707,923

94,271,619,708

2. Prepayments to suppliers

25,316,096,716

13,870,715,589

14,720,646,873

3. Inter-company receivable

0

 

0

4. Receivable according to the progress of construction

0

 

0

5. Other receivable

845,468,340

750,853,603

869,889,256

6. Provisions for bad debts

-2,388,993,969

-2,343,012,074

-2,676,090,560

IV. Inventories

186,746,224,659

244,928,070,355

181,822,330,394

1. Inventories

190,755,424,940

248,633,639,467

188,347,032,878

2. Provisions for devaluation of inventories

-4,009,200,281

-3,705,569,112

-6,524,702,484

V. Other Current Assets

9,415,251,610

9,817,671,027

77,986,311,980

1. Short-term prepaid expenses

922,273

2,332,727

47,665,632

2. VAT to be deducted

6,185,429,506

5,370,727,581

15,777,498,471

3. Taxes and other accounts receivable from the State

0

 

 

4. Other current assets

3,228,899,831

4,444,610,719

62,161,147,877

B. LONG-TERM ASSETS

92,764,580,723

98,661,603,699

98,431,388,784

I. Long term accounts receivable

0

 

 

1. Long term account receivable from customers

0

 

0

2. Working capital in affiliates

0

 

0

3. Long-term inter-company receivable

0

 

0

4. Other long-term receivable

0

 

 

5. Provisions for bad debts from customers

0

 

0

II. Fixed assets

90,727,669,567

96,429,804,772

96,014,925,628

1. Tangible assets

70,776,604,393

84,795,721,844

81,951,668,011

- Historical costs

190,109,231,563

189,342,007,035

170,606,878,021

- Accumulated depreciation

-119,332,627,170

-104,546,285,191

-88,655,210,010

2. Financial leasehold assets

0

638,800,787

830,841,107

- Historical costs

0

1,200,252,000

1,200,252,000

- Accumulated depreciation

0

-561,451,213

-369,410,893

3. Intangible assets

10,114,379,496

10,230,568,709

3,167,833,962

- Initial costs

10,867,260,909

10,867,260,909

3,704,170,000

- Accumulated amortization

-752,881,413

-636,692,200

-536,336,038

4. Construction-in-progress

9,836,685,678

764,713,432

10,064,582,548

III. Investment property

0

 

0

Historical costs

0

 

0

Accumulated depreciation

0

 

0

IV. Long-term investments

0

 

10,000,000

1. Investments in affiliates

0

 

0

2. Investments in business concerns and joint ventures

0

 

0

3. Other long-term investments

0

 

10,000,000

4. Provisions for devaluation of long-term investments

0

 

0

V. Other long-term assets

2,036,911,156

2,231,798,927

2,406,463,156

1. Long-term prepaid expenses

2,036,911,156

2,200,291,427

2,334,608,156

2. Deferred income tax assets

0

 

0

3. Other long-term assets

0

31,507,500

71,855,000

VI. Goodwill

0

 

 

1. Goodwill

0

 

 

TOTAL ASSETS

452,886,567,333

488,619,430,487

528,355,519,070

 

LIABILITIES

A- LIABILITIES

379,470,091,241

413,485,762,247

454,649,113,485

I. Current liabilities

360,813,084,800

382,725,818,437

415,156,687,069

1. Short-term debts and loans

127,785,496,935

157,586,766,325

117,868,223,667

2. Payable to suppliers

108,327,410,467

107,325,218,335

145,669,353,377

3. Advances from customers

99,343,932,846

91,101,664,666

113,711,016,449

4. Taxes and other obligations to the State Budget

6,285,364,117

7,612,995,304

11,498,186,360

5. Payable to employees

8,745,906,425

9,133,261,873

14,269,042,293

6. Accrued expenses

4,451,189,456

6,410,155,554

8,168,217,964

7. Inter-company payable

0

 

0

8. Payable according to the progress of construction contracts

0

 

0

9. Other payable

2,093,027,889

3,535,600,199

3,972,646,959

10. Provisions for short-term accounts payable

20,156,181

20,156,181

0

11. Bonus and welfare funds

3,760,600,484

 

 

II. Long-Term Liabilities

18,657,006,441

30,759,943,810

39,492,426,416

1. Long-term accounts payable to suppliers

0

 

0

2. Long-term inter-company payable

0

 

0

3. Other long-term payable

412,983,009

352,966,009

543,540,415

4. Long-term debts and loans

18,087,160,024

28,829,312,760

37,469,215,461

5. Deferred income tax payable

0

 

0

6. Provisions for unemployment allowances

0

1,420,801,633

1,302,650,951

7. Provisions for long-term accounts payable

156,863,408

156,863,408

177,019,589

8. Unearned Revenue

 

 

 

9. Science and technology development fund

 

 

 

B- OWNER’S EQUITY

73,416,476,092

75,133,668,240

73,706,405,585

I. OWNER’S EQUITY

73,370,776,092

72,073,035,272

71,852,853,073

1. Capital

52,000,000,000

52,000,000,000

52,000,000,000

2. Share premiums

0

 

0

3. Other sources of capital

0

 

0

4. Treasury stocks

0

 

0

5. Differences on asset revaluation

0

 

0

6. Foreign exchange differences

0

 

-533,459,359

7. Business promotion fund

5,584,761,841

4,324,450,685

2,655,092,041

8. Financial reserved fund

2,433,496,884

1,872,313,276

1,037,633,954

9. Other funds

0

 

0

10. Retained earnings

13,352,517,367

13,876,271,311

16,693,586,437

11. Construction investment fund

0

 

0

12. Business arrangement supporting fund

 

 

 

II. Other sources and funds

45,700,000

3,060,632,968

1,853,552,512

1. Bonus and welfare funds (Elder form)

 

3,060,632,968

1,853,552,512

2. Sources of expenditure

45,700,000

 

0

3. Fund to form fixed assets

0

 

0

MINORITY’S INTEREST

0

 

0

TOTAL LIABILITIES AND OWNER’S EQUITY

452,886,567,333

488,619,430,487

528,355,519,070

 

 

PROFIT & LOSS STATEMENT

 

Description

FY2012

FY2011

FY2010

1. Total Sales

818,056,014,213

774,930,463,757

598,323,018,163

2. Deduction item

34,263,926,219

44,220,389,571

13,704,582,177

3. Net revenue

783,792,087,994

730,710,074,186

584,618,435,986

4. Costs of goods sold

604,847,963,390

549,872,790,183

417,381,241,903

5. Gross profit

178,944,124,604

180,837,284,003

167,237,194,083

6. Financial income

2,897,017,681

7,116,430,814

6,519,327,685

7. Financial expenses

30,139,827,512

34,102,478,414

25,669,929,233

- In which: Loan interest expenses

23,147,498,817

24,837,605,833

18,341,150,754

8. Selling expenses

105,615,815,912

107,645,317,570

93,879,681,622

9. Administrative overheads

33,530,191,016

31,192,379,727

31,053,968,617

10. Net operating profit

12,555,307,845

15,013,539,106

23,152,942,296

11. Other income

5,031,737,166

1,350,542,160

1,183,775,620

12. Other expenses

248,387,998

340,530,230

361,622,091

13. Other profit /(loss)

4,783,349,168

1,010,011,930

822,153,530

14. Total accounting profit before tax

17,338,657,013

16,023,551,036

23,975,095,826

15. Current corporate income tax

4,518,548,977

4,267,469,551

7,244,118,725

16. Deferred corporate income tax

 

 

0

17. Interest from subsidiaries/related companies

 

 

 

18. Profit after tax

12,820,108,036

11,756,081,485

16,730,977,099

 

 

FINANCIAL RATIOS AND AVERAGE INDUSTRY RATIOS

 

Description

FY2012

FY2011

FY2010

Average Industry

Current liquidity ratio

1.00

1.02

1.04

1.80

Quick liquidity ratio

0.48

0.38

0.60

1.12

Inventory circle

3.24

2.58

2.30

3.56

Average receive period

67.06

50.94

66.92

117.46

Utilizing asset performance

1.73

1.50

1.11

1.10

Liability by total assets

83.79

84.62

86.05

50.87

Liability by owner's equity

516.87

550.33

616.84

169.03

Ebit / Total assets (ROA)

8.94

8.36

8.01

12.05

Ebit / Owner's equity (ROE)

55.15

54.38

57.41

27.25

Ebit / Total revenue (NPM)

4.95

5.27

7.07

12.32

Gross profit / Total revenue (GPM)

21.87

23.34

27.95

29.69

Note: The Average Industry was calculated by VietnamCredit based on our own statistical data

 

 

CASH FLOW STATEMENT

(Indirect method)

Items

FY2012

FY2011

FY2010

I. Cash flows from operating activities

1. Profit before tax

17,338,657,013

16,023,551,036

23,975,095,824

2. Adjustments

 

 

 

- Depreciation and amortization

16,075,241,863

16,183,471,663

18,848,419,392

- Provisions

349,613,064

-3,152,211,858

1,718,111,306

- Unrealized foreign exchange difference

-184,782,375

-451,784,611

 

- Gain/loss from investing activities

-4,401,804,356

-2,148,441,767

-809,450,794

- Interest expense

23,147,498,817

24,837,605,833

18,341,150,754

3. Operating profit before movements in working capital

52,324,424,026

51,292,190,296

62,073,326,482

- (Increase)/Decrease in receivables

-41,432,078,295

73,704,534,270

-71,967,548,978

- (Increase)/Decrease in inventories

57,878,214,527

-59,327,372,643

-32,489,347,048

- Increase/(Decrease) in accounts payable

8,992,576,553

-62,280,100,510

90,323,857,722

- (Increase)/Decrease in prepaid expenses

164,790,725

179,649,633

-2,376,211,340

- Interest paid

-25,921,308,277

-19,386,843,980

-17,104,461,104

- Corporate income tax paid

-5,267,470,183

-7,289,118,725

-3,022,603,185

- Other cash inflows

815,324,778

4,173,396,610

 

- Other cash outflows

-1,202,875,300

-16,973,380,669

-12,747,713,384

Net cash from (used in) operating activities

46,351,598,554

-35,907,045,718

12,689,299,165

II. Cash flows from investing activities

1. Acquisition of fixed assets and other long - term assets

-10,423,463,134

-16,598,350,807

-7,140,772,468

2. Proceeds from fixed assets and long - term assets disposal

356,849,818

 

-117,833,636

3. Cash outflow for lending, buying debt instruments of other companies

 

 

 

4. Cash recovered from lending, selling debt instruments of other companies

 

 

 

5. Investment in other entities

 

 

 

6. Cash recovered from investments in other entities

 

10,000,000

 

7. Interest income, dividend and profit paid

1,348,889,363

1,995,590,287

3,150,729,759

Net cash from (used in) investing activities

-8,717,723,953

-14,592,760,520

-4,107,876,345

III. Cash flows from financing activities

1. Proceeds from issuing stocks, receiving capital from owners

 

 

 

2. Capital withdrawal, buying back issued stocks

 

 

 

3. Proceeds from borrowings

638,544,678,872

732,678,327,992

518,077,972,915

4. Repayment of borrowings

-679,088,100,998

-701,575,588,035

-554,175,500,806

5. Repayment of obligations under finance leased

 

 

 

6. Dividends paid

-10,356,273,600

-10,298,535,990

-6,076,853,000

Net cash from (used in) financing activities

-50,899,695,726

20,804,203,967

-42,174,380,891

Net increase/(decrease) in cash and cash equivalents

-13,265,821,125

-29,695,602,271

-33,592,958,071

Cash and cash equivalents at beginning of year

33,233,820,365

62,929,422,636

96,522,380,707

Effect from changing foreign exchange rate

 

 

 

Cash and cash equivalents at end of year

19,967,999,240

33,233,820,365

62,929,422,636

 

 

PAYMENT HISTORY & PERFORMANCE EXPERIENCES

 

Trade Morality

 

Good

Liquidity

 

Low/Medium

Payment status

 

Normal

Financial Situation

 

Above Average

Development trend

 

Stable

Litigation data

 

No Record

Bankruptcy

 

No Record

Payment Methods

 

L/C, T/T

Sale Methods

 

Wholesaler

Public opinion

 

Good

 

 

 

INTERPRETATION ON THE SCORES

 

The subject was established in 1960 with name Ich Hoa Sinh Joint– State Private Company. Up to now, it has had very many changes such as organization structure change, registered capital change and name change, etc. Currently, the subject operates under name Nam Ha Pharmaceutical Joint Stock Company. It has business registration No. 0600206147 same to the tax code number, issued by Department of Planning and Investment of Nam Dinh Province. Its registered capital is now VND 52 billion and it has got about 800 labors.

Head office and factory of the subject are located at No. 415 – Han Thuyen Street – Vi Xuyen Ward – Nam Dinh City – Nam Dinh Province. Besides, it has some branches in Hochiminh City, Hanoi City and Danang City. Its facilities are considered good with total area of factory are about 25,000 m2.

The subject is specialized in manufacturing pharmaceutical products under GMP standard, ISO 9001:2008. The materials are imported from many countries. Most of its products are distributed in domestic. Some of its products are popular such as ColDi-B, Bo phe Nam Ha, Skinbibi and Naphar – Mutil...

Based on the latest financial statements of the subject audited by BDO AUDIT CO., LTD, its business result in 2012 is improved in comparison with 2011. Although total assets decreased, total sales and profit in 2012 increased over the previous year. The subject plans to achieve total sale of VND 854 billion and profit before tax of VND 15 billion in 2013.

Following the above financial ratios, its liquidity is limited while the liabilities by total assets and by owner’s equity are larger than the average industry. It is not safe for creditor and itself. The plus point for the subject is short average receive period and high utilizing asset performance. It seems careful in credit policy for its customers.

In general, the subject is large scale company that has operated for a very long time. Its position is remarkable in the business field. The subject is reliable to meet normal transactions. Caution needed for big financial commitments.

 

 

----------- APPENDIX  ----------

 

INDUSTRY DATA

 

Industry code

GDP growth speed by price compared with 1994 (%)

Total enterprises 2010

Total employees 2011

(Thous.pers.)

Annual average capital of enterprises 2010

(billion dongs)

2012

2011

Agriculture, Forestry and Fishing

2.72

4.00

8,887

24,362.9

95,227

Industry and Construction

4.52

5.53

95,217

10,718.9

3,641,376

Trade and Services

6.42

6.69

187,195

15,270.2

6,957,082

 

ECONOMIC INDICATORS

 

 

2012 

2011 

2010 

Population (Million person)

88.78

87.84

86.93

Gross Domestic Products (USD billion)

136

119

102.2

GDP Growth (%)

5.03

5.89

6.78

GDP Per Capita (USD/person/year)

1,540

1,300

1,160

Inflation (% Change in Composite CPI)

9.21

18.58

11.75

State Budget Deficit compared with GDP (%)

4.8

4.9

5.8

 

SERVICE TRADE PERFORMANCE

 

Billion USD 

2012 

2011 

2010 

Exports

114.6

96.3

72.2

Imports

114.3

105.8

84.8

Trade Balance

0.3

-9.5

-12.6

Source: General Statistics Office

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.56.24

UK Pound

1

Rs.84.54

Euro

1

Rs.72.32

 

 

INFORMATION DETAILS

 

Report Prepared by :

PRL

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.